| TGF-beta signaling pathway |
1.51 |
4.74e-1 |
81/94 (86.17%) |
THBS1;ID1;FST;...
|
| Yersinia infection |
1.40 |
4.98e-1 |
120/137 (87.59%) |
PYCARD;MAP2K6;ITGA4;...
|
| p53 signaling pathway |
1.40 |
4.80e-1 |
63/73 (86.3%) |
THBS1;TP53I3;PTEN;...
|
| Hepatitis C |
1.39 |
4.61e-1 |
139/157 (88.54%) |
IFIT1;MX1;OAS1;...
|
| Alcoholism |
1.39 |
4.53e-1 |
86/186 (46.24%) |
PRKACB;GNAS;NTRK2;...
|
| Th17 cell differentiation |
1.37 |
4.80e-1 |
95/107 (88.79%) |
TGFBR2;PRKCQ;IL2RG;...
|
| Hedgehog signaling pathway |
1.34 |
4.94e-1 |
43/56 (76.79%) |
PRKACB;SCUBE2;SMURF2;...
|
| Salmonella infection |
1.33 |
4.97e-1 |
198/249 (79.52%) |
PAK1;PYCARD;PODXL;...
|
| Herpes simplex virus 1 infection |
1.33 |
4.84e-1 |
165/498 (33.13%) |
BST2;CCL5;OAS1;...
|
| Chagas disease |
1.32 |
4.84e-1 |
93/102 (91.18%) |
TGFBR2;GNAS;CCL5;...
|
| Natural killer cell mediated cytotoxicity |
1.32 |
4.74e-1 |
99/131 (75.57%) |
PAK1;BID;LCP2;...
|
| Cocaine addiction |
1.31 |
4.64e-1 |
42/49 (85.71%) |
PRKACB;GNAS;JUN;...
|
| Pathogenic Escherichia coli infection |
1.31 |
4.56e-1 |
152/197 (77.16%) |
PAK1;PYCARD;F2R;...
|
| Sphingolipid signaling pathway |
1.30 |
4.71e-1 |
106/119 (89.08%) |
DEGS1;PTEN;BID;...
|
| Regulation of lipolysis in adipocytes |
1.29 |
4.62e-1 |
52/55 (94.55%) |
CGA;PRKACB;GNAS;...
|
| Epstein-Barr virus infection |
1.29 |
4.54e-1 |
189/202 (93.56%) |
ISG15;MAP2K6;OAS1;...
|
| Fc gamma R-mediated phagocytosis |
1.29 |
4.49e-1 |
79/97 (81.44%) |
PAK1;CRK;ARPC1B;...
|
| Hepatitis B |
1.28 |
4.67e-1 |
151/162 (93.21%) |
TGFBR2;MAP2K6;BID;...
|
| Inflammatory mediator regulation of TRP channels |
1.27 |
4.87e-1 |
82/98 (83.67%) |
PRKCQ;PRKACB;MAP2K6;...
|
| Pancreatic cancer |
1.26 |
4.87e-1 |
75/76 (98.68%) |
TGFBR2;TGFA;E2F3;...
|
| Human cytomegalovirus infection |
1.26 |
4.81e-1 |
201/225 (89.33%) |
CXCL12;PRKACB;MAP2K6;...
|
| Neurotrophin signaling pathway |
1.26 |
4.79e-1 |
107/119 (89.92%) |
CRK;NTRK2;ARHGDIA;...
|
| Chronic myeloid leukemia |
1.24 |
5.00e-1 |
72/76 (94.74%) |
TGFBR2;CRK;E2F3;...
|
| ErbB signaling pathway |
1.24 |
4.98e-1 |
79/85 (92.94%) |
PAK1;TGFA;CBLB;...
|
| Type I diabetes mellitus |
1.24 |
4.94e-1 |
38/43 (88.37%) |
PTPRN2;HLA-DQA1;HLA-DPB1;...
|
| Relaxin signaling pathway |
1.24 |
4.89e-1 |
114/129 (88.37%) |
TGFBR2;PRKACB;GNAS;...
|
| Ribosome biogenesis in eukaryotes |
1.24 |
4.84e-1 |
52/108 (48.15%) |
NVL;HEATR1;POP5;...
|
| Regulation of actin cytoskeleton |
1.23 |
4.84e-1 |
185/218 (84.86%) |
PAK1;F2R;CXCL12;...
|
| Primary bile acid biosynthesis |
1.23 |
4.85e-1 |
15/17 (88.24%) |
AMACR;ACOX2;ACOT8;...
|
| Human papillomavirus infection |
1.22 |
5.02e-1 |
284/331 (85.8%) |
THBS1;THBS2;HEY1;...
|
| Synaptic vesicle cycle |
-1.33 |
3.19e-1 |
63/78 (80.77%) |
ATP6V0A4;STX1A;DNM1;...
|
| Glycerophospholipid metabolism |
-1.34 |
3.18e-1 |
71/98 (72.45%) |
CHKB;PLA2G2D;PLD1;...
|
| alpha-Linolenic acid metabolism |
-1.34 |
3.21e-1 |
17/25 (68%) |
PLAAT3;ACAA1;FADS2;...
|
| Transcriptional misregulation in cancer |
-1.35 |
3.23e-1 |
158/192 (82.29%) |
KMT2A;CEBPB;HDAC1;...
|
| Central carbon metabolism in cancer |
-1.39 |
2.88e-1 |
67/70 (95.71%) |
PIK3CB;LDHC;HK3;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.42 |
2.35e-1 |
49/77 (63.64%) |
GSTM3;CYP2D6;CYP1B1;...
|
| Amoebiasis |
-1.43 |
2.37e-1 |
99/102 (97.06%) |
LAMB2;ITGB2;COL1A2;...
|
| Neutrophil extracellular trap formation |
-1.43 |
2.40e-1 |
101/189 (53.44%) |
PLCB3;FCGR2A;AGER;...
|
| Steroid hormone biosynthesis |
-1.44 |
2.30e-1 |
43/61 (70.49%) |
CYP3A7;CYP3A5;SRD5A1;...
|
| Dilated cardiomyopathy |
-1.46 |
2.15e-1 |
86/96 (89.58%) |
ATP2A3;SGCA;CACNA1D;...
|
| Maturity onset diabetes of the young |
-1.47 |
1.99e-1 |
21/26 (80.77%) |
SLC2A2;ONECUT1;MNX1;...
|
| Selenocompound metabolism |
-1.49 |
1.81e-1 |
11/17 (64.71%) |
PAPSS1;CTH;SEPHS1;...
|
| Ether lipid metabolism |
-1.50 |
1.86e-1 |
32/49 (65.31%) |
PLA2G4A;PAFAH1B1;PLA2G12A;...
|
| Cardiac muscle contraction |
-1.50 |
1.96e-1 |
64/87 (73.56%) |
RYR2;ATP1B1;COX6A1;...
|
| Insulin resistance |
-1.50 |
2.06e-1 |
96/108 (88.89%) |
INS;IRS1;SREBF1;...
|
| Fructose and mannose metabolism |
-1.52 |
1.90e-1 |
30/33 (90.91%) |
ALDOB;TKFC;HK2;...
|
| Carbohydrate digestion and absorption |
-1.52 |
2.03e-1 |
37/47 (78.72%) |
SLC2A2;ATP1B1;SLC5A1;...
|
| Porphyrin and chlorophyll metabolism |
-1.53 |
2.04e-1 |
23/43 (53.49%) |
COX10;CP;FECH;...
|
| African trypanosomiasis |
-1.53 |
2.14e-1 |
32/37 (86.49%) |
ICAM1;IL10;LAMA4;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
-1.55 |
2.11e-1 |
70/77 (90.91%) |
ATP2A3;SGCA;CACNA1D;...
|
| Ferroptosis |
-1.58 |
1.80e-1 |
36/41 (87.8%) |
CP;MAP1LC3B;ATG7;...
|
| Vitamin digestion and absorption |
-1.59 |
1.67e-1 |
17/24 (70.83%) |
PNLIP;ABCC1;SLC19A2;...
|
| Starch and sucrose metabolism |
-1.62 |
1.43e-1 |
25/36 (69.44%) |
PYGM;PYGB;HK2;...
|
| Pancreatic secretion |
-1.65 |
1.20e-1 |
87/102 (85.29%) |
ADCY9;PLA2G2D;KCNMA1;...
|
| Fat digestion and absorption |
-1.66 |
1.22e-1 |
35/43 (81.4%) |
PNLIP;PLA2G12A;CLPS;...
|
| Renin-angiotensin system |
-1.74 |
6.37e-2 |
20/23 (86.96%) |
MME;KLK1;ANPEP;...
|
| Retinol metabolism |
-1.74 |
7.52e-2 |
41/68 (60.29%) |
CYP3A7;CYP3A5;AOX1;...
|
| Type II diabetes mellitus |
-1.77 |
7.67e-2 |
42/46 (91.3%) |
SOCS2;PIK3CB;HK3;...
|
| Hypertrophic cardiomyopathy |
-1.81 |
7.08e-2 |
81/90 (90%) |
ATP2A3;SGCA;CACNA1D;...
|
| Protein digestion and absorption |
-1.86 |
7.96e-2 |
78/103 (75.73%) |
COL4A4;ATP1B1;COL9A3;...
|